1. Home
  2. FOIL vs CORT Comparison

FOIL vs CORT Comparison

Compare FOIL & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FOIL

Londian Wason New Energy Tech Inc. American Depositary Shares each representing five Ordinary Shares

N/A

Current Price

$18.93

Market Cap

8.6B

Sector

Industrials

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$117.02

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOIL
CORT
Founded
N/A
1998
Country
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
9.7B
IPO Year
2024
2001

Fundamental Metrics

Financial Performance
Metric
FOIL
CORT
Price
$18.93
$117.02
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$96.50
AVG Volume (30 Days)
26.9K
843.5K
Earning Date
N/A
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.09
Revenue
N/A
$761,407,000.00
Revenue This Year
N/A
$26.08
Revenue Next Year
N/A
$26.98
P/E Ratio
N/A
$1,264.00
Revenue Growth
N/A
12.79
52 Week Low
$19.00
$28.66
52 Week High
$25.44
$126.38

Technical Indicators

Market Signals
Indicator
FOIL
CORT
Relative Strength Index (RSI) 26.41 51.60
Support Level $19.50 $108.25
Resistance Level $23.27 $124.30
Average True Range (ATR) 1.32 5.07
MACD -0.16 -0.65
Stochastic Oscillator 17.67 52.64

Price Performance

Historical Comparison
FOIL
CORT

About FOIL Londian Wason New Energy Tech Inc. American Depositary Shares each representing five Ordinary Shares

Londian Wason New Energy Tech Inc is engaged in the research, development, and manufacture of electrolytic copper foil. Its product portfolio includes lithium-ion battery (LiB) copper foil, printed circuit board (PCB)-grade copper foil, and flexible copper clad laminates (FCCLs). Its products are used in applications including electric vehicles, energy storage systems, communication equipment, and consumer electronics. The company derives its revenue from contracts with customers, including the sales of LiB copper foil, PCB-grade copper foil and others in the PRC.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: